COMPANY INFO
Rejuvenation Technologies Inc. is a biotechnology company founded in 2018 by John Ramunas and Glenn Markov. The company, headquartered in Mountain View, California, has approximately 23 employees and focuses on developing nucleoside-modified TERT mRNA therapeutics to extend telomeres and treat age-related diseases. Their technology aims to safely and rapidly extend telomeres to increase cellular proliferative capacity, targeting regenerative medicine and age-related conditions. The official website is https://rejuvenationtech.com, and the company operates primarily in the drug discovery and biotechnology industries.
Rejuvenation Technologies is an innovative biotechnology company founded in 2018 by John Ramunas and Glenn Markov, and headquartered in Mountain View, California. Specializing in the development of nucleoside-modified TERT mRNA therapeutics, Rejuvenation Technologies aims to extend telomeres and treat age-related diseases by increasing cellular proliferative capacity. With approximately 23 employees, the company targets advancements in regenerative medicine and drug discovery, focusing on therapies that can safely and rapidly rejuvenate aging tissues.
Rejuvenation Technologies funding history showcases a strategic combination of grants and venture investments to accelerate its cutting-edge research and development. To date, Rejuvenation Technologies has secured approximately $15.2 million through 7 funding rounds, including significant seed funding and support from prominent investors and government grants. Key milestones include major seed investment rounds to fuel both product development and early-stage market growth, as well as a series of grants facilitating ongoing research. The company’s funding strategy leverages a blend of venture capital and non-dilutive grant funding, positioning it to advance both proprietary technology and clinical development programs.
This recent grant round was awarded to support ongoing research and development initiatives, helping to propel Rejuvenation Technologies' therapeutic programs forward.
This grant was utilized to enhance ongoing research and further the development of next-generation mRNA-based therapeutics.
This seed round was used for product development and early-stage company growth, enabling the push towards preclinical and early commercial milestones.
A major infusion of seed funding dedicated to supporting product development and initial market expansion as the company scaled its R&D and operational efforts.
This grant helped fund research support, advancing the company’s underlying scientific programs and experimental therapeutics.
Awarded for early research, this non-dilutive funding supported foundational studies and proof-of-concept work.
This initial round of grant funding contributed to the earliest research and development activities at Rejuvenation Technologies.
Khosla Ventures, a well-known venture capital firm, led one of the seed funding rounds for Rejuvenation Technologies. Their investment supports the company's mission to advance breakthrough therapeutics in the biotechnology sector.
LifeSpan Vision Ventures participated as a lead investor in a seed funding round, playing a strategic role in supporting Rejuvenation Technologies’ early-stage product development and company growth trajectory.
Shanda, a global investment group, co-led a significant seed funding round, helping strengthen the company's financial foundation for research and market expansion.
HHS has been a consistent grant provider to Rejuvenation Technologies, awarding several rounds of non-dilutive funding to fuel the company’s ongoing and early-stage research.
Y Combinator, a renowned accelerator and seed investor, has also contributed to Rejuvenation Technologies, providing guidance and capital for the company's startup journey.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Rejuvenation Technologies funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.